A 3-Treatment, 3-Period, 6-Sequence Randomized Crossover Single-Dose Study Evaluating the Bioequivalence of High-Load and Low-Load Oral Tablet Formulations of Apx001 and the Effect of Food on the Absorption of Apx001 From the High-Load Tablet In Healthy Subjects
Latest Information Update: 19 Jul 2024
At a glance
- Drugs Fosmanogepix (Primary)
- Indications Mycoses
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
Most Recent Events
- 12 Aug 2022 New trial record